Company profile: StatLab
1.1 - Company Overview
Company description
- Provider of diagnostic supplies for the anatomic pathology lab market, developing and manufacturing cost-effective histology, cytology, and immunohistochemistry products. Offerings include large-format tissue processing cassettes, histology reagents, slides and cassettes, paraffin embedding wax, cytology collection devices, fixatives, stains, accessories, and microbiology consumables such as sterile, control, and printed diagnostic slides.
Products and services
- Histology Reagents: Laboratory-grade chemical reagents used for tissue processing, staining, and embedding in anatomic pathology labs, supporting cost-effective diagnostic workflows across independent and hospital-based histology settings
- Cytology Products: Clinical-grade traditional and liquid-based cytology components, including collection devices, fixatives, stains, and accessories, enabling specimen collection, fixation, and staining for diagnostic cytology in anatomic pathology laboratories
- Histology Slides and Cassettes: Standardized assemblies used to hold and organize tissue samples during histology processing and analysis in anatomic pathology laboratories
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to StatLab
Alderys
HQ: France
Website
- Description: Provider of innovative biological engineering approaches to produce chemical compounds of economic interest from renewable plant resources, including nutrients via rectified biosynthetic routes, targeting convenience chemicals, cosmetics, and animal nutrition markets, with environmentally respectful industrial technological solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Alderys company profile →
Remedy Plan
HQ: United States
Website
- Description: Provider of pre-clinical cancer therapeutics developing first-in-class small molecule drugs that differentiate cancer cells, including RPT1G, a clinical candidate targeting NAMPT for solid and hematological malignancies. Offers NAMPT programs in oncology, autoimmune, and obesity, and a proprietary high-throughput phenotypic drug screening platform targeting critical pathways in cancer stem cells.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Remedy Plan company profile →
Immunophotonics
HQ: United States
Website
- Description: Provider of immunotherapy-based cancer treatments, including IP-001, a proprietary glycan polymer that stimulates immune responses against cancer and infectious diseases by acting as an antigen depot and immune activator; and an Abscopalizing Technique involving IP-001 injection with tumor ablation or radiation to induce a systemic immune response against cancer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Immunophotonics company profile →
Mablink Bioscience
HQ: France
Website
- Description: Provider of biotechnology focused on developing a new class of cancer drugs, Antibody Drug Conjugate (ADC).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mablink Bioscience company profile →
BioDtech
HQ: United States
Website
- Description: Provider of reagents and systems for the detection, neutralization, and removal of endotoxin for researchers in bioresearch and bioprocess markets, offering detection solutions including EndoDtec-F to uncover bacteria in environmental samples, injectable drugs, and medical devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioDtech company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for StatLab
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to StatLab
2.2 - Growth funds investing in similar companies to StatLab
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for StatLab
4.2 - Public trading comparable groups for StatLab
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →